{"product_id":"respiratory-diagnostics-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eRespiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global respiratory diagnostics market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eRespiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.\u003c\/p\u003e\n\n\u003cp\u003eThe growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R\u0026amp;D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory diagnostics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product and service type, test type, disease and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product and Service Type:\u003c\/p\u003e\n\n\u003cp\u003eInstruments and Services\u003cbr\u003e\nAssays and Reagents\u003cbr\u003e\nServices and Software\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Test Type:\u003c\/p\u003e\n\n\u003cp\u003eMechanical Tests\u003cbr\u003e\nObstructive Sleep Apnoea (OSA) Diagnostic Tests\u003cbr\u003e\nImaging Tests\u003cbr\u003e\nTraditional Diagnostic Tests\u003cbr\u003e\nMolecular Diagnostic Tests\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Disease:\u003c\/p\u003e\n\n\u003cp\u003eTuberculosis\u003cbr\u003e\nAsthma\u003cbr\u003e\nChronic Obstructive Pulmonary Disease (COPD)\u003cbr\u003e\nLung Cancer\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nClinics\u003cbr\u003e\nReference and Clinical Laboratories\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nEurope\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\nLatin America\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global respiratory diagnostics market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat are the key regional markets in the global respiratory diagnostics industry?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global respiratory diagnostics industry?\u003cbr\u003e\nWhat is the breakup of the market based on the product and service type?\u003cbr\u003e\nWhat is the breakup of the market based on the test type?\u003cbr\u003e\nWhat is the breakup of the market based on the disease?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat are the various stages in the value chain of the global respiratory diagnostics industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the global respiratory diagnostics industry?\u003cbr\u003e\nWhat is the structure of the global respiratory diagnostics industry and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the global respiratory diagnostics industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 145 Pages \/ MCW16237360","offer_id":47652446503218,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/respiratory-diagnostics-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}